Additional karyotype abnormalities in t(8;21) associated acute myeloblastic leukemia (AML)

MLA

Fleishman, E. V., et al. Additional Karyotype Abnormalities in t(8;21) Associated Acute Myeloblastic Leukemia (AML). EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..c9836bf9e308c26e9a6c8e4121c2b00a&authtype=sso&custid=ns315887. Accessed 13 Dec. 2024.

APA

Fleishman, E. V., Olga Sokova, Popa, A. V., Baturina, Y. A., Konstantinova, L. N., Kirichenko, O. P., Baranova, O. Y., & Andreeva, L. Y. (n.d.). Additional karyotype abnormalities in t(8;21) associated acute myeloblastic leukemia (AML).

Chicago

Fleishman, E. V., Olga Sokova, A. V. Popa, Yu A. Baturina, L. N. Konstantinova, O. P. Kirichenko, O. Yu Baranova, and L. Yu Andreeva. 2024. “Additional Karyotype Abnormalities in t(8;21) Associated Acute Myeloblastic Leukemia (AML).” Accessed December 13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..c9836bf9e308c26e9a6c8e4121c2b00a&authtype=sso&custid=ns315887.